nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP3A4—Temozolomide—malignant glioma	0.129	1	CbGbCtD
Levonorgestrel—SRD5A1—telencephalon—malignant glioma	0.0103	0.141	CbGeAlD
Levonorgestrel—Haemorrhoids—Temozolomide—malignant glioma	0.0085	0.0227	CcSEcCtD
Levonorgestrel—Cyst—Carmustine—malignant glioma	0.00774	0.0207	CcSEcCtD
Levonorgestrel—Tooth disorder—Temozolomide—malignant glioma	0.00771	0.0206	CcSEcCtD
Levonorgestrel—Influenza-like symptoms—Temozolomide—malignant glioma	0.007	0.0187	CcSEcCtD
Levonorgestrel—PGR—blood vessel—malignant glioma	0.00696	0.0954	CbGeAlD
Levonorgestrel—Menorrhagia—Temozolomide—malignant glioma	0.00675	0.0181	CcSEcCtD
Levonorgestrel—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00675	0.0181	CcSEcCtD
Levonorgestrel—Otitis media—Temozolomide—malignant glioma	0.00642	0.0172	CcSEcCtD
Levonorgestrel—Endocrine disorder—Temozolomide—malignant glioma	0.00603	0.0161	CcSEcCtD
Levonorgestrel—SRD5A1—central nervous system—malignant glioma	0.00585	0.0802	CbGeAlD
Levonorgestrel—Breast pain—Temozolomide—malignant glioma	0.00573	0.0153	CcSEcCtD
Levonorgestrel—Amenorrhoea—Temozolomide—malignant glioma	0.00569	0.0152	CcSEcCtD
Levonorgestrel—ESR1—blood vessel—malignant glioma	0.00544	0.0746	CbGeAlD
Levonorgestrel—Herpes simplex—Temozolomide—malignant glioma	0.00542	0.0145	CcSEcCtD
Levonorgestrel—Musculoskeletal pain—Temozolomide—malignant glioma	0.00506	0.0135	CcSEcCtD
Levonorgestrel—Urinary incontinence—Carmustine—malignant glioma	0.005	0.0134	CcSEcCtD
Levonorgestrel—Candida infection—Carmustine—malignant glioma	0.00494	0.0132	CcSEcCtD
Levonorgestrel—Influenza like illness—Temozolomide—malignant glioma	0.00485	0.013	CcSEcCtD
Levonorgestrel—Urinary incontinence—Temozolomide—malignant glioma	0.00483	0.0129	CcSEcCtD
Levonorgestrel—Candida infection—Temozolomide—malignant glioma	0.00477	0.0128	CcSEcCtD
Levonorgestrel—Vaginal infection—Temozolomide—malignant glioma	0.00472	0.0126	CcSEcCtD
Levonorgestrel—Neoplasm—Carmustine—malignant glioma	0.00468	0.0125	CcSEcCtD
Levonorgestrel—SRD5A1—brain—malignant glioma	0.00464	0.0637	CbGeAlD
Levonorgestrel—Neoplasm—Temozolomide—malignant glioma	0.00452	0.0121	CcSEcCtD
Levonorgestrel—Abnormal vision—Carmustine—malignant glioma	0.00451	0.0121	CcSEcCtD
Levonorgestrel—Abnormal vision—Temozolomide—malignant glioma	0.00436	0.0117	CcSEcCtD
Levonorgestrel—SHBG—brainstem—malignant glioma	0.00422	0.0579	CbGeAlD
Levonorgestrel—Vascular purpura—Temozolomide—malignant glioma	0.00406	0.0109	CcSEcCtD
Levonorgestrel—Purpura—Temozolomide—malignant glioma	0.00377	0.0101	CcSEcCtD
Levonorgestrel—Affect lability—Temozolomide—malignant glioma	0.00357	0.00956	CcSEcCtD
Levonorgestrel—Mood swings—Temozolomide—malignant glioma	0.00344	0.0092	CcSEcCtD
Levonorgestrel—Dry skin—Temozolomide—malignant glioma	0.00333	0.0089	CcSEcCtD
Levonorgestrel—Breast disorder—Temozolomide—malignant glioma	0.00328	0.00877	CcSEcCtD
Levonorgestrel—ESR1—embryo—malignant glioma	0.00325	0.0445	CbGeAlD
Levonorgestrel—Abdominal distension—Temozolomide—malignant glioma	0.00316	0.00845	CcSEcCtD
Levonorgestrel—Sweating increased—Temozolomide—malignant glioma	0.00306	0.00817	CcSEcCtD
Levonorgestrel—Bronchitis—Temozolomide—malignant glioma	0.00302	0.00807	CcSEcCtD
Levonorgestrel—ESR1—brainstem—malignant glioma	0.00298	0.0408	CbGeAlD
Levonorgestrel—Dysuria—Temozolomide—malignant glioma	0.00293	0.00785	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00291	0.0078	CcSEcCtD
Levonorgestrel—Pneumonia—Carmustine—malignant glioma	0.00291	0.00779	CcSEcCtD
Levonorgestrel—Pollakiuria—Temozolomide—malignant glioma	0.0029	0.00775	CcSEcCtD
Levonorgestrel—Depression—Carmustine—malignant glioma	0.00289	0.00772	CcSEcCtD
Levonorgestrel—Weight increased—Temozolomide—malignant glioma	0.00285	0.00764	CcSEcCtD
Levonorgestrel—Weight decreased—Temozolomide—malignant glioma	0.00284	0.00759	CcSEcCtD
Levonorgestrel—Urinary tract infection—Carmustine—malignant glioma	0.00281	0.00753	CcSEcCtD
Levonorgestrel—Pneumonia—Temozolomide—malignant glioma	0.00281	0.00753	CcSEcCtD
Levonorgestrel—Infestation NOS—Temozolomide—malignant glioma	0.0028	0.00748	CcSEcCtD
Levonorgestrel—Infestation—Temozolomide—malignant glioma	0.0028	0.00748	CcSEcCtD
Levonorgestrel—Depression—Temozolomide—malignant glioma	0.00279	0.00746	CcSEcCtD
Levonorgestrel—Urinary tract infection—Temozolomide—malignant glioma	0.00272	0.00727	CcSEcCtD
Levonorgestrel—AR—telencephalon—malignant glioma	0.00269	0.0369	CbGeAlD
Levonorgestrel—ESR1—telencephalon—malignant glioma	0.00264	0.0362	CbGeAlD
Levonorgestrel—Sinusitis—Temozolomide—malignant glioma	0.00262	0.00702	CcSEcCtD
Levonorgestrel—Haemoglobin—Carmustine—malignant glioma	0.00261	0.00699	CcSEcCtD
Levonorgestrel—Haemorrhage—Carmustine—malignant glioma	0.0026	0.00695	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Carmustine—malignant glioma	0.00258	0.00692	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Carmustine—malignant glioma	0.00255	0.00683	CcSEcCtD
Levonorgestrel—Haemoglobin—Temozolomide—malignant glioma	0.00252	0.00675	CcSEcCtD
Levonorgestrel—Haemorrhage—Temozolomide—malignant glioma	0.00251	0.00672	CcSEcCtD
Levonorgestrel—Visual impairment—Carmustine—malignant glioma	0.0025	0.0067	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Temozolomide—malignant glioma	0.0025	0.00668	CcSEcCtD
Levonorgestrel—Pharyngitis—Temozolomide—malignant glioma	0.00249	0.00667	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Temozolomide—malignant glioma	0.00248	0.00663	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Temozolomide—malignant glioma	0.00247	0.0066	CcSEcCtD
Levonorgestrel—Urethral disorder—Temozolomide—malignant glioma	0.00246	0.00658	CcSEcCtD
Levonorgestrel—Eye disorder—Carmustine—malignant glioma	0.00243	0.0065	CcSEcCtD
Levonorgestrel—Visual impairment—Temozolomide—malignant glioma	0.00242	0.00647	CcSEcCtD
Levonorgestrel—Erythema multiforme—Temozolomide—malignant glioma	0.00237	0.00635	CcSEcCtD
Levonorgestrel—Eye disorder—Temozolomide—malignant glioma	0.00235	0.00628	CcSEcCtD
Levonorgestrel—Cardiac disorder—Temozolomide—malignant glioma	0.00233	0.00623	CcSEcCtD
Levonorgestrel—Arrhythmia—Carmustine—malignant glioma	0.00232	0.00621	CcSEcCtD
Levonorgestrel—Alopecia—Carmustine—malignant glioma	0.0023	0.00614	CcSEcCtD
Levonorgestrel—Mental disorder—Carmustine—malignant glioma	0.00228	0.00609	CcSEcCtD
Levonorgestrel—Immune system disorder—Temozolomide—malignant glioma	0.00227	0.00607	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Temozolomide—malignant glioma	0.00226	0.00605	CcSEcCtD
Levonorgestrel—Erythema—Carmustine—malignant glioma	0.00226	0.00605	CcSEcCtD
Levonorgestrel—Malnutrition—Carmustine—malignant glioma	0.00226	0.00605	CcSEcCtD
Levonorgestrel—Alopecia—Temozolomide—malignant glioma	0.00222	0.00594	CcSEcCtD
Levonorgestrel—Mental disorder—Temozolomide—malignant glioma	0.0022	0.00588	CcSEcCtD
Levonorgestrel—Back pain—Carmustine—malignant glioma	0.00219	0.00585	CcSEcCtD
Levonorgestrel—Malnutrition—Temozolomide—malignant glioma	0.00219	0.00585	CcSEcCtD
Levonorgestrel—Erythema—Temozolomide—malignant glioma	0.00219	0.00585	CcSEcCtD
Levonorgestrel—SHBG—central nervous system—malignant glioma	0.00213	0.0292	CbGeAlD
Levonorgestrel—Back pain—Temozolomide—malignant glioma	0.00211	0.00566	CcSEcCtD
Levonorgestrel—Anaemia—Carmustine—malignant glioma	0.00209	0.00559	CcSEcCtD
Levonorgestrel—SHBG—cerebellum—malignant glioma	0.00208	0.0286	CbGeAlD
Levonorgestrel—Anaemia—Temozolomide—malignant glioma	0.00202	0.0054	CcSEcCtD
Levonorgestrel—Angioedema—Temozolomide—malignant glioma	0.002	0.00534	CcSEcCtD
Levonorgestrel—Vertigo—Temozolomide—malignant glioma	0.00196	0.00525	CcSEcCtD
Levonorgestrel—Hypertension—Carmustine—malignant glioma	0.00195	0.00522	CcSEcCtD
Levonorgestrel—Palpitations—Temozolomide—malignant glioma	0.00193	0.00517	CcSEcCtD
Levonorgestrel—Chest pain—Carmustine—malignant glioma	0.00193	0.00515	CcSEcCtD
Levonorgestrel—Myalgia—Carmustine—malignant glioma	0.00193	0.00515	CcSEcCtD
Levonorgestrel—PGR—central nervous system—malignant glioma	0.00192	0.0263	CbGeAlD
Levonorgestrel—Anxiety—Carmustine—malignant glioma	0.00192	0.00513	CcSEcCtD
Levonorgestrel—Cough—Temozolomide—malignant glioma	0.00191	0.0051	CcSEcCtD
Levonorgestrel—Hypertension—Temozolomide—malignant glioma	0.00189	0.00505	CcSEcCtD
Levonorgestrel—AR—spinal cord—malignant glioma	0.00188	0.0258	CbGeAlD
Levonorgestrel—PGR—cerebellum—malignant glioma	0.00188	0.0257	CbGeAlD
Levonorgestrel—Myalgia—Temozolomide—malignant glioma	0.00186	0.00498	CcSEcCtD
Levonorgestrel—Anxiety—Temozolomide—malignant glioma	0.00185	0.00496	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00185	0.00494	CcSEcCtD
Levonorgestrel—Oedema—Carmustine—malignant glioma	0.00185	0.00494	CcSEcCtD
Levonorgestrel—Discomfort—Temozolomide—malignant glioma	0.00184	0.00492	CcSEcCtD
Levonorgestrel—Infection—Carmustine—malignant glioma	0.00183	0.00491	CcSEcCtD
Levonorgestrel—Oedema—Temozolomide—malignant glioma	0.00178	0.00477	CcSEcCtD
Levonorgestrel—Infection—Temozolomide—malignant glioma	0.00177	0.00474	CcSEcCtD
Levonorgestrel—Anorexia—Carmustine—malignant glioma	0.00176	0.00471	CcSEcCtD
Levonorgestrel—Nervous system disorder—Temozolomide—malignant glioma	0.00175	0.00468	CcSEcCtD
Levonorgestrel—Skin disorder—Temozolomide—malignant glioma	0.00173	0.00463	CcSEcCtD
Levonorgestrel—CYP19A1—central nervous system—malignant glioma	0.00173	0.0237	CbGeAlD
Levonorgestrel—Hyperhidrosis—Temozolomide—malignant glioma	0.00172	0.00461	CcSEcCtD
Levonorgestrel—Anorexia—Temozolomide—malignant glioma	0.0017	0.00455	CcSEcCtD
Levonorgestrel—SHBG—brain—malignant glioma	0.00169	0.0232	CbGeAlD
Levonorgestrel—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00168	0.0045	CcSEcCtD
Levonorgestrel—Insomnia—Carmustine—malignant glioma	0.00167	0.00447	CcSEcCtD
Levonorgestrel—Dyspnoea—Carmustine—malignant glioma	0.00165	0.0044	CcSEcCtD
Levonorgestrel—Somnolence—Carmustine—malignant glioma	0.00164	0.00439	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00162	0.00435	CcSEcCtD
Levonorgestrel—Insomnia—Temozolomide—malignant glioma	0.00161	0.00432	CcSEcCtD
Levonorgestrel—Decreased appetite—Carmustine—malignant glioma	0.0016	0.00429	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Carmustine—malignant glioma	0.00159	0.00426	CcSEcCtD
Levonorgestrel—Dyspnoea—Temozolomide—malignant glioma	0.00159	0.00425	CcSEcCtD
Levonorgestrel—Somnolence—Temozolomide—malignant glioma	0.00159	0.00424	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—CYP2B6—malignant glioma	0.00158	0.409	CrCbGaD
Levonorgestrel—Pain—Carmustine—malignant glioma	0.00158	0.00422	CcSEcCtD
Levonorgestrel—Constipation—Carmustine—malignant glioma	0.00158	0.00422	CcSEcCtD
Levonorgestrel—Dyspepsia—Temozolomide—malignant glioma	0.00157	0.0042	CcSEcCtD
Levonorgestrel—Decreased appetite—Temozolomide—malignant glioma	0.00155	0.00415	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00154	0.00412	CcSEcCtD
Levonorgestrel—Fatigue—Temozolomide—malignant glioma	0.00154	0.00411	CcSEcCtD
Levonorgestrel—AR—central nervous system—malignant glioma	0.00153	0.021	CbGeAlD
Levonorgestrel—Constipation—Temozolomide—malignant glioma	0.00153	0.00408	CcSEcCtD
Levonorgestrel—Pain—Temozolomide—malignant glioma	0.00153	0.00408	CcSEcCtD
Levonorgestrel—PGR—brain—malignant glioma	0.00152	0.0209	CbGeAlD
Levonorgestrel—Gastrointestinal pain—Carmustine—malignant glioma	0.00151	0.00404	CcSEcCtD
Levonorgestrel—ESR1—central nervous system—malignant glioma	0.0015	0.0206	CbGeAlD
Levonorgestrel—ESR1—cerebellum—malignant glioma	0.00147	0.0201	CbGeAlD
Levonorgestrel—Abdominal pain—Carmustine—malignant glioma	0.00146	0.0039	CcSEcCtD
Levonorgestrel—Body temperature increased—Carmustine—malignant glioma	0.00146	0.0039	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Temozolomide—malignant glioma	0.00146	0.0039	CcSEcCtD
Levonorgestrel—Methyltestosterone—CYP2B6—malignant glioma	0.00145	0.374	CrCbGaD
Levonorgestrel—Urticaria—Temozolomide—malignant glioma	0.00142	0.00379	CcSEcCtD
Levonorgestrel—Abdominal pain—Temozolomide—malignant glioma	0.00141	0.00377	CcSEcCtD
Levonorgestrel—Body temperature increased—Temozolomide—malignant glioma	0.00141	0.00377	CcSEcCtD
Levonorgestrel—CYP19A1—brain—malignant glioma	0.00137	0.0188	CbGeAlD
Levonorgestrel—Hypersensitivity—Carmustine—malignant glioma	0.00136	0.00364	CcSEcCtD
Levonorgestrel—Asthenia—Carmustine—malignant glioma	0.00132	0.00354	CcSEcCtD
Levonorgestrel—Hypersensitivity—Temozolomide—malignant glioma	0.00131	0.00352	CcSEcCtD
Levonorgestrel—Asthenia—Temozolomide—malignant glioma	0.00128	0.00342	CcSEcCtD
Levonorgestrel—Diarrhoea—Carmustine—malignant glioma	0.00126	0.00338	CcSEcCtD
Levonorgestrel—Pruritus—Temozolomide—malignant glioma	0.00126	0.00338	CcSEcCtD
Levonorgestrel—Dizziness—Carmustine—malignant glioma	0.00122	0.00327	CcSEcCtD
Levonorgestrel—Diarrhoea—Temozolomide—malignant glioma	0.00122	0.00326	CcSEcCtD
Levonorgestrel—AR—brain—malignant glioma	0.00121	0.0166	CbGeAlD
Levonorgestrel—ESR1—brain—malignant glioma	0.00119	0.0163	CbGeAlD
Levonorgestrel—Dizziness—Temozolomide—malignant glioma	0.00118	0.00316	CcSEcCtD
Levonorgestrel—Vomiting—Carmustine—malignant glioma	0.00117	0.00314	CcSEcCtD
Levonorgestrel—Rash—Carmustine—malignant glioma	0.00116	0.00311	CcSEcCtD
Levonorgestrel—Dermatitis—Carmustine—malignant glioma	0.00116	0.00311	CcSEcCtD
Levonorgestrel—Headache—Carmustine—malignant glioma	0.00116	0.00309	CcSEcCtD
Levonorgestrel—Vomiting—Temozolomide—malignant glioma	0.00113	0.00303	CcSEcCtD
Levonorgestrel—Rash—Temozolomide—malignant glioma	0.00112	0.00301	CcSEcCtD
Levonorgestrel—Dermatitis—Temozolomide—malignant glioma	0.00112	0.00301	CcSEcCtD
Levonorgestrel—Headache—Temozolomide—malignant glioma	0.00112	0.00299	CcSEcCtD
Levonorgestrel—Nausea—Carmustine—malignant glioma	0.0011	0.00293	CcSEcCtD
Levonorgestrel—Nausea—Temozolomide—malignant glioma	0.00106	0.00283	CcSEcCtD
Levonorgestrel—Testosterone—CYP2B6—malignant glioma	0.000839	0.217	CrCbGaD
Levonorgestrel—CYP3A4—central nervous system—malignant glioma	0.000837	0.0115	CbGeAlD
Levonorgestrel—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000233	0.000553	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000232	0.00055	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HEY1—malignant glioma	0.00023	0.000546	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR4—malignant glioma	0.00023	0.000546	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000227	0.00054	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH2—malignant glioma	0.000223	0.00053	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIST1H3B—malignant glioma	0.000223	0.00053	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000222	0.000527	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—IDH2—malignant glioma	0.000221	0.000525	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00022	0.000524	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00022	0.000523	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000219	0.000522	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000219	0.00052	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000218	0.000519	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000215	0.000512	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—malignant glioma	0.000214	0.000509	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTEN—malignant glioma	0.00021	0.000499	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000208	0.000495	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000208	0.000493	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—DNMT3B—malignant glioma	0.000207	0.000492	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000206	0.00049	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JAG2—malignant glioma	0.000204	0.000484	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000203	0.000483	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—KRAS—malignant glioma	0.000202	0.000481	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000202	0.00048	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—H3F3A—malignant glioma	0.000202	0.00048	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HIST1H3B—malignant glioma	0.000201	0.000478	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000201	0.000478	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000198	0.000471	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000198	0.000471	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000194	0.000462	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MDK—malignant glioma	0.000194	0.000462	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CDKN2B—malignant glioma	0.000192	0.000456	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—IDH1—malignant glioma	0.00019	0.000451	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH3—malignant glioma	0.000189	0.00045	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	0.000186	0.000442	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DTX1—malignant glioma	0.000185	0.000441	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000184	0.000437	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000182	0.000433	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NCOR1—malignant glioma	0.000182	0.000432	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000181	0.00043	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.00018	0.000428	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000178	0.000424	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000174	0.000414	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—H3F3A—malignant glioma	0.000172	0.000409	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000172	0.000409	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCR3—malignant glioma	0.000171	0.000405	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00017	0.000405	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH2—malignant glioma	0.00017	0.000404	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00017	0.000404	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00017	0.000404	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00017	0.000403	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000168	0.0004	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000168	0.0004	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—YWHAE—malignant glioma	0.000166	0.000394	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK2—malignant glioma	0.000166	0.000394	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FLT1—malignant glioma	0.000165	0.000393	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—DUSP6—malignant glioma	0.000164	0.000391	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000164	0.00039	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JAG1—malignant glioma	0.000162	0.000386	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH3—malignant glioma	0.000162	0.000384	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FBXW7—malignant glioma	0.000159	0.000378	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	0.000159	0.000378	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BDKRB2—malignant glioma	0.000156	0.000371	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—H3F3A—malignant glioma	0.000155	0.00037	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000155	0.000368	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000155	0.000367	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—malignant glioma	0.000154	0.000367	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000153	0.000363	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—malignant glioma	0.000152	0.000361	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00015	0.000356	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000149	0.000355	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—malignant glioma	0.000148	0.000352	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SUFU—malignant glioma	0.000147	0.00035	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CDKN2B—malignant glioma	0.000146	0.000347	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH3—malignant glioma	0.000146	0.000347	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000146	0.000346	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HEY2—malignant glioma	0.000145	0.000346	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH2—malignant glioma	0.000145	0.000345	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GFAP—malignant glioma	0.000142	0.000338	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KNG1—malignant glioma	0.000142	0.000337	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NCOR1—malignant glioma	0.000139	0.000329	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH1—malignant glioma	0.000138	0.000328	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SPHK1—malignant glioma	0.000137	0.000327	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000136	0.000324	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000136	0.000323	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK1—malignant glioma	0.000135	0.000322	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HEY1—malignant glioma	0.000135	0.00032	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR4—malignant glioma	0.000135	0.00032	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH2—malignant glioma	0.000131	0.000311	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000131	0.000311	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—malignant glioma	0.00013	0.00031	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—BCHE—malignant glioma	0.000127	0.000301	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000126	0.000301	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP3—malignant glioma	0.000126	0.000299	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000125	0.000298	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN2B—malignant glioma	0.000125	0.000296	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTK2—malignant glioma	0.000121	0.000288	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—malignant glioma	0.000121	0.000287	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JAG2—malignant glioma	0.000119	0.000284	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES1—malignant glioma	0.000119	0.000283	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000118	0.000282	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCOR1—malignant glioma	0.000118	0.000281	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000118	0.000279	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000117	0.000279	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDGFRA—malignant glioma	0.000113	0.000269	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CDKN2B—malignant glioma	0.000113	0.000267	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SPP1—malignant glioma	0.00011	0.000261	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NCOR1—malignant glioma	0.000107	0.000254	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH1—malignant glioma	0.000105	0.00025	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TERT—malignant glioma	0.000104	0.000248	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000102	0.000243	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDGFB—malignant glioma	0.000102	0.000242	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGFR1—malignant glioma	0.000101	0.00024	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—H3F3A—malignant glioma	0.000101	0.00024	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—malignant glioma	0.000101	0.00024	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCR3—malignant glioma	0.0001	0.000238	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COX8A—malignant glioma	0.0001	0.000238	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIF1A—malignant glioma	9.96e-05	0.000237	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—malignant glioma	9.93e-05	0.000236	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAT—malignant glioma	9.82e-05	0.000233	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—YWHAE—malignant glioma	9.74e-05	0.000231	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK2—malignant glioma	9.74e-05	0.000231	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FLT1—malignant glioma	9.7e-05	0.00023	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DUSP6—malignant glioma	9.65e-05	0.000229	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—malignant glioma	9.64e-05	0.000229	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JAG1—malignant glioma	9.53e-05	0.000227	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—malignant glioma	9.53e-05	0.000227	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH3—malignant glioma	9.49e-05	0.000226	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FBXW7—malignant glioma	9.34e-05	0.000222	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NCOR1—malignant glioma	9.27e-05	0.00022	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FN1—malignant glioma	9.17e-05	0.000218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—malignant glioma	9.17e-05	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BDKRB2—malignant glioma	9.16e-05	0.000218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BAD—malignant glioma	9.06e-05	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—malignant glioma	9.06e-05	0.000215	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH1—malignant glioma	8.98e-05	0.000213	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CD80—malignant glioma	8.8e-05	0.000209	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APC—malignant glioma	8.78e-05	0.000209	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—malignant glioma	8.78e-05	0.000209	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGF—malignant glioma	8.68e-05	0.000206	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTPN11—malignant glioma	8.63e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH2—malignant glioma	8.51e-05	0.000202	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ASMT—malignant glioma	8.5e-05	0.000202	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KNG1—malignant glioma	8.33e-05	0.000198	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BRAF—malignant glioma	8.25e-05	0.000196	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH1—malignant glioma	8.1e-05	0.000193	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT2—malignant glioma	8.03e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BCAN—malignant glioma	7.99e-05	0.00019	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK1—malignant glioma	7.94e-05	0.000189	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CD—malignant glioma	7.72e-05	0.000183	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—malignant glioma	7.65e-05	0.000182	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—malignant glioma	7.56e-05	0.00018	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—malignant glioma	7.43e-05	0.000177	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF2—malignant glioma	7.39e-05	0.000176	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP3—malignant glioma	7.38e-05	0.000175	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN2B—malignant glioma	7.32e-05	0.000174	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.22e-05	0.000172	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTK2—malignant glioma	7.1e-05	0.000169	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES1—malignant glioma	6.98e-05	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCOR1—malignant glioma	6.94e-05	0.000165	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MDM2—malignant glioma	6.91e-05	0.000164	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RAF1—malignant glioma	6.89e-05	0.000164	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—malignant glioma	6.88e-05	0.000164	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB2—malignant glioma	6.82e-05	0.000162	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CB—malignant glioma	6.73e-05	0.00016	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDGFRA—malignant glioma	6.65e-05	0.000158	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—malignant glioma	6.64e-05	0.000158	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—malignant glioma	6.46e-05	0.000154	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SPP1—malignant glioma	6.45e-05	0.000153	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—IDH2—malignant glioma	6.44e-05	0.000153	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—malignant glioma	6.19e-05	0.000147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—malignant glioma	6.18e-05	0.000147	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TERT—malignant glioma	6.12e-05	0.000145	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.06e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CD—malignant glioma	6.05e-05	0.000144	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDGFB—malignant glioma	5.97e-05	0.000142	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGFR1—malignant glioma	5.94e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIF1A—malignant glioma	5.85e-05	0.000139	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—malignant glioma	5.85e-05	0.000139	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTEN—malignant glioma	5.81e-05	0.000138	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—malignant glioma	5.66e-05	0.000135	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—malignant glioma	5.66e-05	0.000134	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—malignant glioma	5.59e-05	0.000133	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—IDH1—malignant glioma	5.54e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FN1—malignant glioma	5.38e-05	0.000128	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—malignant glioma	5.38e-05	0.000128	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SPHK1—malignant glioma	5.36e-05	0.000127	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BAD—malignant glioma	5.32e-05	0.000126	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CB—malignant glioma	5.27e-05	0.000125	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH1—malignant glioma	5.27e-05	0.000125	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.25e-05	0.000125	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—malignant glioma	5.25e-05	0.000125	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—malignant glioma	5.23e-05	0.000124	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—malignant glioma	5.2e-05	0.000124	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CD80—malignant glioma	5.16e-05	0.000123	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APC—malignant glioma	5.15e-05	0.000122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—malignant glioma	5.15e-05	0.000122	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—malignant glioma	5.15e-05	0.000122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGF—malignant glioma	5.09e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTPN11—malignant glioma	5.06e-05	0.00012	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BRAF—malignant glioma	4.84e-05	0.000115	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—malignant glioma	4.83e-05	0.000115	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—malignant glioma	4.72e-05	0.000112	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT2—malignant glioma	4.71e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTEN—malignant glioma	4.56e-05	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CD—malignant glioma	4.53e-05	0.000108	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KRAS—malignant glioma	4.46e-05	0.000106	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—malignant glioma	4.36e-05	0.000104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF2—malignant glioma	4.34e-05	0.000103	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—malignant glioma	4.25e-05	0.000101	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—malignant glioma	4.1e-05	9.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MDM2—malignant glioma	4.06e-05	9.65e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RAF1—malignant glioma	4.04e-05	9.61e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB2—malignant glioma	4e-05	9.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS1—malignant glioma	3.98e-05	9.46e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—malignant glioma	3.97e-05	9.43e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CB—malignant glioma	3.95e-05	9.38e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—malignant glioma	3.93e-05	9.33e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—malignant glioma	3.79e-05	9.02e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BCHE—malignant glioma	3.7e-05	8.79e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.65e-05	8.69e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—malignant glioma	3.63e-05	8.63e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—malignant glioma	3.63e-05	8.62e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—malignant glioma	3.43e-05	8.16e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTEN—malignant glioma	3.41e-05	8.11e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—malignant glioma	3.35e-05	7.96e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—malignant glioma	3.22e-05	7.64e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—malignant glioma	3.08e-05	7.32e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—malignant glioma	3.05e-05	7.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—malignant glioma	3.02e-05	7.19e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—malignant glioma	2.94e-05	7e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAT—malignant glioma	2.86e-05	6.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—malignant glioma	2.84e-05	6.74e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—malignant glioma	2.77e-05	6.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NCOR1—malignant glioma	2.71e-05	6.43e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—malignant glioma	2.63e-05	6.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KRAS—malignant glioma	2.62e-05	6.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—malignant glioma	2.41e-05	5.72e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—malignant glioma	2.33e-05	5.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—malignant glioma	2.21e-05	5.24e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.01e-05	4.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—malignant glioma	1.97e-05	4.67e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—malignant glioma	1.94e-05	4.61e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.77e-05	4.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.54e-05	3.66e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—malignant glioma	1.53e-05	3.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTEN—malignant glioma	1.33e-05	3.16e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.38e-06	2.23e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—malignant glioma	7.66e-06	1.82e-05	CbGpPWpGaD
